The journal couples issues devoted to Russian literature with contributions on and from Croatian, Serbian, Czech, Slovak and Polish literature. Languages of publication are English and Russian; in exceptional cases articles in French or German are accepted. All methods and viewpoints will be welcomed, provided they contribute something new, original or challenging to our understanding of Russian and other Slavic literatures. Original full-length research papers which have not been published previously may be submitted as regular papers. Where of undisputed merit to the field, the journal also accepts previously unpublished literary materials. The solicited article length is 8000-9000 words maximum (excl. bibliography). In exceptional cases (where the format or the type of material dictates so), longer articles are accepted.
Contact details for submission
The author is requested to send an anonymized PDF version of the submission to the Editor-in-Chief, Prof.dr. Ellen Rutten, via firstname.lastname@example.org. We ask authors to submit their names, addresses and e-mail addresses in an accompanying email. The reading/reviewing process takes roughly four months, after which the author will be informed about the editorial decision. If this is positive, the editor expects a final version (which includes author affiliation details and email address) and an abstract (the latter in English, not exceeding 100 words), both to be sent electronically (as word.doc only), which can be emailed to email@example.com.
Please see our information pages on Ethics in publishing and Ethical guidelines for journal publication.
Declaration of interest
All authors are requested to disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations within three years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work. More information.
Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis or as an electronic preprint, see 'Multiple, redundant or concurrent publication' section of our ethics policy for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere including electronically in the same form, in English or in any other language, without the written consent of the copyright-holder.
Changes to authorship
Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.
Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum.
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations. If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases.For open access articles: Upon acceptance of an article, authors will be asked to complete an 'Exclusive License Agreement' (more information). Permitted third party reuse of open access articles is determined by the author's choice of user license.
As an author you (or your employer or institution) have certain rights to reuse your work. More information.
Find out how you can share your research published in Elsevier journals.
Role of the funding source
You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.
Elsevier has established a number of agreements with funding bodies which allow authors to comply with their funder's open access policies. Some funding bodies will reimburse the author for the Open Access Publication Fee. Details of existing agreements are available online.
• Articles are freely available to both subscribers and the wider public with permitted reuse.
• An open access publication fee is payable by authors or on their behalf, e.g. by their research funder or institution.
• Articles are made available to subscribers as well as developing countries and patient groups through our universal access programs.
• No open access publication fee payable by authors.
Regardless of how you choose to publish your article, the journal will apply the same peer review criteria and acceptance standards.For open access articles, permitted third party (re)use is defined by the following Creative Commons user licenses:
Creative Commons Attribution (CC BY)
Lets others distribute and copy the article, create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), include in a collective work (such as an anthology), text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.
For non-commercial purposes, lets others distribute and copy the article, and to include in a collective work (such as an anthology), as long as they credit the author(s) and provided they do not alter or modify the article.
The open access publication fee for this journal is USD 1100, excluding taxes. Learn more about Elsevier's pricing policy: http://www.elsevier.com/openaccesspricing.
Green open access
Authors can share their research in a variety of different ways and Elsevier has a number of green open access options available. We recommend authors see our green open access page for further information. Authors can also self-archive their manuscripts immediately and enable public access from their institution's repository after an embargo period. This is the version that has been accepted for publication and which typically includes author-incorporated changes suggested during submission, peer review and in editor-author communications. Embargo period: For subscription articles, an appropriate amount of time is needed for journals to deliver value to subscribing customers before an article becomes freely available to the public. This is the embargo period and it begins from the date the article is formally published online in its final and fully citable form. Find out more.
This journal has an embargo period of 24 months.
An adapted embargo period of 12 months will apply for UK researchers who are grant recipient from the Research Council UK, Wellcome Trust, Higher Education Funding Council for England, and who wish to self-archive their accepted author manuscript. For more information, please follow this link.
The Elsevier Publishing Campus (www.publishingcampus.com) is an online platform offering free lectures, interactive training and professional advice to support you in publishing your research. The College of Skills training offers modules on how to prepare, write and structure your article and explains how editors will look at your paper when it is submitted for publication. Use these resources, and more, to ensure that your submission will be the best that you can make it.
Language (usage and editing services)
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service available from Elsevier's WebShop.
Articles in English may be in American or British English, but should be written consistently in whichever is chosen. However, original spelling in quotations should be retained. Manuscripts should be typewritten first copies or full-quality prints with a wide margin and double spacing throughout, i.e. also for abstracts, endnotes and references. Every page of the manuscript, including the title page, references, etc. should be numbered. Please use one side of the paper only. Keep the layout of the text as simple as possible. Do not justify text or split up words. The first page should be the title page containing full title, short title (maximum 40 letters including spaces) and author's name, postal address and e-mail address. In case of a Russian author's name and an article in English please indicate the desired transcription; if not the editors will use the scientific transliteration. In case of a non-Russian author's name and a Russian language article please state the desired transcription/transliteration in Cyrillic. The author is requested to indicate how his/her name should be alphabetized.
Russian Literature uses the scientific (or international library) transliteration of Cyrillic. Please use this transliteration consistently throughout the article.
Title: Titles of articles, essays, stories, "povesti", novellas, poems, "poemas", cycles should be in single quotes.
Titles of novels, periodicals, plays, books should be given in italics.
Translations: Preference is given to original Russian titles (English translations may be given in parentheses). If translated titles are used, the original title should be given in parentheses at least at the first occurrence.
Quotations should be given in the original language. Translations of quotations in the Slavic languages are desirable and should follow the original - in parentheses.
• Title. Concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae where possible.
• Author names and affiliations. Please clearly indicate the given name(s) and family name(s) of each author and check that all names are accurately spelled. Present the authors' affiliation addresses (where the actual work was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address. Provide the full postal address of each affiliation, including the country name and, if available, the e-mail address of each author.
• Corresponding author. Clearly indicate who will handle correspondence at all stages of refereeing and publication, also post-publication. Ensure that the e-mail address is given and that contact details are kept up to date by the corresponding author.
• Present/permanent address. If an author has moved since the work described in the article was done, or was visiting at the time, a 'Present address' (or 'Permanent address') may be indicated as a footnote to that author's name. The address at which the author actually did the work must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.
A concise and factual abstract is required, both in the language in which the paper has been written and in British or American English. The abstract should state briefly the purpose of the research, the principal results and major conclusions. An abstract is often presented separately from the article, so it must be able to stand alone. For this reason, References should be avoided, but if essential, then cite the author(s) and year(s). Also, non-standard or uncommon abbreviations should be avoided, but if essential they must be defined at their first mention in the abstract itself.
Immediately after the English abstract, provide a maximum of 6 keywords, using British or American English spelling and avoiding general and plural terms and multiple concepts (avoid, for example, "and", "of"). Be sparing with abbreviations: only abbreviations firmly established in the field may be eligible. These keywords will be used for indexing purposes.
Collate acknowledgements in a separate section at the end of the article before the references and do not, therefore, include them on the title page, as a footnote to the title or otherwise. List here those individuals who provided help during the research (e.g., providing language help, writing assistance or proof reading the article, etc.).
List funding sources in this standard way to facilitate compliance to funder's requirements:
Funding: This work was supported by the National Institutes of Health [grant numbers xxxx, yyyy]; the Bill & Melinda Gates Foundation, Seattle, WA [grant number zzzz]; and the United States Institutes of Peace [grant number aaaa].It is not necessary to include detailed descriptions on the program or type of grants and awards. When funding is from a block grant or other resources available to a university, college, or other research institution, submit the name of the institute or organization that provided the funding.
If no funding has been provided for the research, please include the following sentence:This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Footnotes should be used sparingly. Number them consecutively throughout the article, using superscript Arabic numbers. Many wordprocessors build footnotes into the text, and this feature may be used. Should this not be the case, indicate the position of footnotes in the text and present the footnotes themselves separately at the end of the article. Do not include footnotes in the Reference list.
References may be given in accordance with two systems:
* A full list of references is given at the end of the article. Reference in the main text and notes (if any) is then made by name, year, semicolon, single space, page number(s) in parentheses. Do not repeat the name if it is mentioned in the main text.
1) As Sapir has already noted: "All grammars leak" (1921: 37)
2) The well-known maxim "All grammars leak" (Sapir 1921: 37)
* References may also be given in endnotes. Full bibliographical data should be supplied at the first occurrence; later references may be abbreviated - by the use of op.cit., followed by page number. However, the full data should be repeated if any confusion with other works referred to might arise.
In all cases references should be given in conformity with the following:
Titles of articles should be in single quotes, titles of books and periodicals in italics. Names of periodicals should be followed by year, volume and issue numbers, and by the article's page numbers. Titles of books should be followed by place and year of publication (publishers should be omitted.
This journal enables you to show an Interactive Plot with your article by simply submitting a data file. Full instructions.
The final version of an article is the definitive one: proofs will not be sent. If an author, after having submitted the final version of the article, still wants to make any changes, he/she should contact the Editor-in-Chief or Managing Editor.
The corresponding author will, at no cost, receive a customized Share Link providing 50 days free access to the final published version of the article on ScienceDirect. The Share Link can be used for sharing the article via any communication channel, including email and social media. For an extra charge, paper offprints can be ordered via the offprint order form which is sent once the article is accepted for publication. Both corresponding and co-authors may order offprints at any time via Elsevier's Webshop. Corresponding authors who have published their article open access do not receive a Share Link as their final published version of the article is available open access on ScienceDirect and can be shared through the article DOI link.